Capitolis Liquid Global Markets
INBX icon

Capitolis Liquid Global Markets’s Inhibrx INBX Stock Holding History

Capitolis Liquid Global Markets’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.9M Hold
119,200
– – 0.05% 178
2026
Q2 		$11.3M Sell
119,200
-5,800
-5% -$581K 0.05% 187
2026
Q1 		$8.4M Buy
+125,000
New +$9.27M 0.05% 199

Other funds holding INBX

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Capitolis Liquid Global Markets's INBX Position: Q3 2026 in Review

Capitolis Liquid Global Markets held its Inhibrx (INBX) position steady in Q3 2026 at 119,200 shares worth $11.9M. The position accounts for 0.05% of the portfolio, ranked #178.

Capitolis Liquid Global Markets first reported a position in INBX in Q1 2026 and has held it in 3 quarters since. 89 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Capitolis Liquid Global Markets held 119,200 shares of Inhibrx worth $11.9M as of Q3 2026.
  • Capitolis Liquid Global Markets left its Inhibrx share count unchanged in Q3 2026.
  • Inhibrx made up 0.05% of Capitolis Liquid Global Markets's portfolio in Q3 2026, its #178 holding.
  • Capitolis Liquid Global Markets first reported a position in Inhibrx in Q1 2026 and has held it in 3 quarters since.
  • 89 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q3 2026, filed 12 Nov 2026.